£203.99

Bridging the Gap: In This Era of Cancer Immunotherapy (Cancer Etiology, Diagnosis and Treatments)

Oncology

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£204 today · previous high £204 · all-time low £154

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical

Generating forecast...

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £154 (83 days, 92.2%)

Price range: £154 - £204

Price levels: 2 different prices over 90 days

Description

Recognizing rare diseases' impracticability of having extensive clinical trials necessary for regulatory approval, the US Orphan Drug Act appropriately facilitates the commercialization of "orphan drugs". However, even common cancers also have rather specific but uncommon clinical situations for which extensive clinical trials are hardly practicable. Moreover, although such very costly and extensive trials often depend on industry support, uncommon situations are unattractive. Eventually, many specific treatments for designated clinical oncology situations often lack regulatory approvals merely because of suboptimal trial data. Now, this EBM (evidence-based medicine) book by expert authors with first-hand clinical experience is about off-label but acceptable treatment options. The attempt is to patch up the low response rates and considerable adverse events of novel immunotherapy. Currently, without any such off-label treatments, some cancer patients may well be left out in the cold. Although off-label treatments lack regulatory approval, they are backed by EBM and have good safety profiles. It's inappropriate to announce "nothing else can be done" merely because all approved options have already been exhausted. In expert hands, despite the "on compassionate grounds" proviso, the safety profiles of such off-label prescriptions may even compare favorably with orthodox chemotherapy given at top doses.

Product Specifications

Format: hardcover
ASIN: 1536199001
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 11 August 2021
Listed Since: 30 July 2021

Barcode

No barcode data available

Bridging the Gap: In This Era of Cancer Immunotherapy (Cancer Etiology, Diagnosis and Treatments)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Experimental and Applied Immunotherapy

Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs

Experimental and Applied Immunotherapy

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

Oncologic Emergency Medicine: Principles and Practice

Advances in Brain Tumor Therapy: From Molecular Mechanisms to Clinical Practice

Immuno-Oncology: From Bench to Bedside

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Immunotherapy for Gastrointestinal Cancer

Immunotherapy for Pediatric Malignancies

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Brain Tumor Immunotherapy

Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)

Nanotechnology in Brain Tumor Treatment: Unveiling Molecular Mechanisms and Pioneering Therapies

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)

Nutraceuticals and Cancer

Integrative Medicine for Breast Cancer: An Evidence-Based Assessment

Biosimilars in Cancer

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Cancer Immunotherapy: Paradigms, Practice and Promise

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)